SUN PHARMA ADVANCED RESEARCH COMPANY
Back to Balance Sheet
|
SUN PHARMA ADVANCED RESEARCH COMPANY Last 5 Year Contingent Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | |
|---|---|---|---|
| Contingent Liabilities | ₹51 Cr | ₹84 Cr | ₹84 Cr |
What is the latest Contingent Liabilities ratio of SUN PHARMA ADVANCED RESEARCH COMPANY ?
| Year | Contingent Liabilities |
|---|---|
| Mar2025 | ₹51 Cr |
| Mar2024 | ₹84 Cr |
| Mar2023 | ₹84 Cr |
How is Contingent Liabilities of SUN PHARMA ADVANCED RESEARCH COMPANY Trending?
| Years | Contingent Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹51 Cr | -39.38 | |
| Mar2024 | ₹84 Cr | 0.00 | |
| Mar2023 | ₹84 Cr | - | |
Compare Contingent Liabilities of peers of SUN PHARMA ADVANCED RESEARCH COMPANY
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SUN PHARMA ADVANCED RESEARCH COMPANY | ₹4,937.3 Cr | 4.2% | 24.6% | 5.5% | Stock Analytics | |
| SAGILITY INDIA | ₹20,199.9 Cr | 1% | 9.3% | 9.7% | Stock Analytics | |
| SYNGENE INTERNATIONAL | ₹17,515.8 Cr | 10.5% | 7.6% | -40.5% | Stock Analytics | |
| LATENT VIEW ANALYTICS | ₹6,381.6 Cr | 3.4% | 4.6% | -15.9% | Stock Analytics | |
| JUST DIAL | ₹4,628.1 Cr | -4.1% | 3.9% | -32% | Stock Analytics | |
| AWFIS SPACE SOLUTIONS | ₹2,612.3 Cr | 17.5% | 28% | -42.8% | Stock Analytics | |
SUN PHARMA ADVANCED RESEARCH COMPANY Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SUN PHARMA ADVANCED RESEARCH COMPANY | 4.2% |
24.6% |
5.5% |
| SENSEX | 0.6% |
1.5% |
6.6% |
You may also like the below Video Courses